Study to Investigate Hepatic Impairment on PK, Safety, Tolerability of Camizestrant in Post-Menopausal Female Subjects

Trial Identifier: D8532C00002
Start Date:February 2023
Primary Completion Date: October 2023
Study Completion Date: October 2023
Condition: Liver, Pancreas & Gallbladder - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

US, TX San Antonio, TX, US, 78215
US, TX San Antonio, TX, US, 78229
BG Sofia, BG, 1612
SK Bratislava, SK, 831 01